Diroximel fumarate is a pharmaceutical raw material used in the manufacturing of active pharmaceutical ingredients for relapsing forms of multiple sclerosis. It is a fumarate compound designed to be bioequivalent to dimethyl fumarate but with a modified chemical structure intended to reduce gastrointestinal side effects.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1577222-14-0
IFN-gamma Antagonist
pharmaceutical raw material
2-(2-Amino-1,3-thiazol-4-yl)-N-(4-(2-((2-phenylethyl)amino)ethyl)phenyl)acetamide
pharmaceutical raw material
Cromolyn sodium
pharmaceutical raw material
Irofulven
pharmaceutical raw material
4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate
YIMYDTCOUQIDMT-SNAWJCMRSA-N
COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O